REGENXBIO Inc. (RGNX) Operating income 2016–2025
REGENXBIO Inc. (RGNX) annual operating income history from SEC filings — each fiscal year as reported.
-$161.2MFY2025 · since FY2016: -$65.3M → -$161.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$161.2M | +30.9% |
| FY2024 | -$233.3M | +13.0% |
| FY2023 | -$268.1M | -2.0% |
| FY2022 | -$262.9M | -264.3% |
| FY2021 | $160.0M | +234.2% |
| FY2020 | -$119.2M | +20.0% |
| FY2019 | -$149.0M | -269.1% |
| FY2018 | $88.1M | +216.1% |
| FY2017 | -$75.9M | -16.1% |
| FY2016 | -$65.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice